Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis
dc.contributor.author | Bundred, James R | |
dc.contributor.author | Michael, Sarah | |
dc.contributor.author | Stewart, Beth | |
dc.contributor.author | Cutress, Ramsey | |
dc.contributor.author | Beckmann, Kerri R. | |
dc.contributor.author | Holleczek, Bernd | |
dc.contributor.author | Dahlstrom, Jane | |
dc.contributor.author | Gath, Jacqui | |
dc.contributor.author | Dodwell, David | |
dc.contributor.author | Bundred, Nigel J | |
dc.date.accessioned | 2024-05-13T05:23:50Z | |
dc.date.available | 2024-05-13T05:23:50Z | |
dc.date.issued | 2022 | |
dc.date.updated | 2023-01-15T07:17:18Z | |
dc.description.abstract | Objective To determine if margin involvement is associated with distant recurrence and to determine the required margin to minimise both local recurrence and distant recurrence in early stage invasive breast cancer. Design Prospectively registered systematic review and meta-analysis of literature. Data sources Medline (PubMed), Embase, and Proquest online databases. Unpublished data were sought from study authors. Eligibility criteria Eligible studies reported on patients undergoing breast conserving surgery (for stages I-III breast cancer), allowed an estimation of outcomes in relation to margin status, and followed up patients for a minimum of 60 months. Patients with ductal carcinoma in situ only or treated with neoadjuvant chemotherapy or by mastectomy were excluded. Where applicable, margins were categorised as tumour on ink (involved), close margins (no tumour on ink but <2 mm), and negative margins (≥2 mm). Results 68 studies from 1 January 1980 to 31 December 2021, comprising 112 140 patients with breast cancer, were included. Across all studies, 9.4% (95% confidence interval 6.8% to 12.8%) of patients had involved (tumour on ink) margins and 17.8% (13.0% to 23.9%) had tumour on ink or a close margin. The rate of distant recurrence was 25.4% (14.5% to 40.6%) in patients with tumour on ink, 8.4% (4.4% to 15.5%) in patients with tumour on ink or close, and 7.4% (3.9% to 13.6%) in patients with negative margins. Compared with negative margins, tumour on ink margins were associated with increased distant recurrence (hazard ratio 2.10, 95% confidence interval 1.65 to 2.69, P<0.001) and local recurrence (1.98, 1.66 to 2.36, P<0.001). Close margins were associated with increased distant recurrence (1.38, 1.13 to 1.69, P<0.001) and local recurrence (2.09, 1.39 to 3.13, P<0.001) compared with negative margins, after adjusting for receipt of adjuvant chemotherapy and radiotherapy. In five studies published since 2010, tumour on ink margins were associated with increased distant recurrence (2.41, 1.81 to 3.21, P<0.001) as were tumour on ink and close margins (1.44, 1.22 to 1.71, P<0.001) compared with negative margins. Conclusions Involved or close pathological margins after breast conserving surgery for early stage, invasive breast cancer are associated with increased distant recurrence and local recurrence. Surgeons should aim to achieve a minimum clear margin of at least 1 mm. On the basis of current evidence, international guidelines should be revised. | en_AU |
dc.description.sponsorship | DD received funding from Cancer Research UK (C8225/A21133). | en_AU |
dc.format.mimetype | application/pdf | en_AU |
dc.identifier.issn | 0959-8138 | en_AU |
dc.identifier.uri | http://hdl.handle.net/1885/317476 | |
dc.language.iso | en_AU | en_AU |
dc.provenance | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. | en_AU |
dc.publisher | British Medical Association | en_AU |
dc.rights | © 2022 The authors | en_AU |
dc.rights.license | Creative Commons Attribution licence | en_AU |
dc.rights.uri | http://creativecommons.org/licenses/ by-nc-nd/4.0/ | en_AU |
dc.source | BMJ (Clinical research ed.) | en_AU |
dc.title | Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | en_AU |
dc.type | Journal article | en_AU |
dcterms.accessRights | Open Access | en_AU |
local.bibliographicCitation.startpage | e070346 | en_AU |
local.contributor.affiliation | Bundred, James R , Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK | en_AU |
local.contributor.affiliation | Michael, Sarah, Division of Cancer Sciences, University of Manchester, Manchester, UK | en_AU |
local.contributor.affiliation | Stewart, Beth, Cancer Sciences, University of Southampton, Southampton, UK | en_AU |
local.contributor.affiliation | Cutress, Ramsey, Cancer Sciences, University of Southampton, Southampton, UK | en_AU |
local.contributor.affiliation | Beckmann, Kerri R., The University of Adelaide | en_AU |
local.contributor.affiliation | Holleczek, Bernd, Division of Clinical Epidemiology Aging Research, German Cancer Research Centre (DKFZ), Heidelberg, Germany | en_AU |
local.contributor.affiliation | Dahlstrom, Jane, College of Health and Medicine, ANU | en_AU |
local.contributor.affiliation | Gath, Jacqui, Independent Cancer Patients' Voice, London, UK | en_AU |
local.contributor.affiliation | Dodwell, David, Nuffield Department of Population Health, University of Oxford, Oxford, UK | en_AU |
local.contributor.affiliation | Bundred, Nigel J , Division of Cancer Sciences, University of Manchester, Manchester, UK | en_AU |
local.contributor.authoremail | u3725583@anu.edu.au | en_AU |
local.contributor.authoruid | Dahlstrom, Jane, u3725583 | en_AU |
local.description.notes | Imported from ARIES | en_AU |
local.identifier.absfor | 321104 - Cancer therapy (excl. chemotherapy and radiation therapy) | en_AU |
local.identifier.absseo | 200105 - Treatment of human diseases and conditions | en_AU |
local.identifier.ariespublication | a383154xPUB35860 | en_AU |
local.identifier.citationvolume | 378 | en_AU |
local.identifier.doi | 10.1136/bmj-2022-070346 | en_AU |
local.identifier.scopusID | 2-s2.0-85138227113 | |
local.identifier.uidSubmittedBy | a383154 | en_AU |
local.publisher.url | https://www.bmj.com/ | en_AU |
local.type.status | Published Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- bmj-2022-070346.full.pdf
- Size:
- 1.07 MB
- Format:
- Adobe Portable Document Format
- Description: